JPH0434968B2 - - Google Patents

Info

Publication number
JPH0434968B2
JPH0434968B2 JP59228973A JP22897384A JPH0434968B2 JP H0434968 B2 JPH0434968 B2 JP H0434968B2 JP 59228973 A JP59228973 A JP 59228973A JP 22897384 A JP22897384 A JP 22897384A JP H0434968 B2 JPH0434968 B2 JP H0434968B2
Authority
JP
Japan
Prior art keywords
maltol
growth
bacteria
present
caries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59228973A
Other languages
Japanese (ja)
Other versions
JPS61109716A (en
Inventor
Hideaki Myawaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIYO KORYO KK
Original Assignee
TAIYO KORYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAIYO KORYO KK filed Critical TAIYO KORYO KK
Priority to JP22897384A priority Critical patent/JPS61109716A/en
Publication of JPS61109716A publication Critical patent/JPS61109716A/en
Publication of JPH0434968B2 publication Critical patent/JPH0434968B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

(産業上の利用分野) 本発明はう蝕(虫歯)の形成に大きく関与して
いるストレプトコツカス・ミユータンス
(Streptococcus mutans)に代表される口腔内細
菌に対して優れた抗菌活性を示す、う蝕菌生育阻
害剤に関する。 (従来の技術) 従来、口腔内細菌の生育を阻害する薬剤として
はクロルヘキシジン、抗生物質等の使用が知られ
ている外、多くの合成品、天然品が報告されてい
る。 (発明が解決しようとする問題点) しかしながら、これら公知の口腔内細菌の生育
阻害剤は投与方法、投与量によつては人体に対す
る安全性に問題があつたり、安定性が確認されて
いるものは抗菌性が低かつたり、また投与した
際、不快な臭がするなどの欠点があつた。 本発明の目的は人体に対する安全性が確認され
ており、且つ抗菌性が高く、しかも快い芳香を有
するう蝕菌生育阻害剤を提供することにある。 (問題点を解決するための手段) 本発明によれば、マルトール及び/またはエチ
ルマルトールを有効成分として含有することを特
徴とするう蝕菌生育阻害剤が提供される。 以下本発明につき更に詳細に説明する。 一般にう蝕(虫歯)形成の原因としては歯質
(Teeth)と基質(Substrate)とミユータンス菌
(St.mutans)とを挙げることができ、この3つ
の要因が同時に存在するとき、う蝕(虫歯)が発
生するとされている。う蝕(虫歯)形成のメカニ
ズムは、例えば糖類の中で砂糖を基質
(Substrate)とした場合、この砂糖がミユータン
ス菌(St.mutans)の産出するグルコキシトラン
スフエラーゼ(酵素)によつ水に不溶性で粘着性
のデキストラン(グルカン)に変化し、歯質
(Teeth)の表面に歯垢を形成する。この歯垢の
中では嫌気状態となり乳酸菌等により醗酵が進み
乳酸が生成してPHが低下し、この乳酸が歯のエ
ナメル質を脱灰しう蝕(虫歯)を形成するとされ
ている。 従つて、ストレプトコツカス・ミユータンス
(St.mutans)に代表される口腔内細菌の増殖を
抑え歯垢の形成を阻止することはう蝕(虫歯)の
形成を予防する有効な方法である。本発明者等は
既に人体に安全性が確認され且う蝕(虫歯)形成
に大きく関与しているストレプトコツカス・ミユ
ータンス菌(St.mutans)の生育を阻害する条件
に適合する物質を鋭意探索研究した結果、マルト
ール及び/またはエチルマルトールが非常に有効
であることを見出し、本発明を完成するに至つ
た。 本発明にて用いるマルトール及びエチルマルト
ールはすでに公知物質であり、下記に差の化学構
造式及び化学名を示す。 3−ハイドロキシ−2−メチル−4−ピロン
(マルトール) 3−ハイドロキシ−2−エチル−4−ピロン
(エチルマルトール) 本発明にて用いるマルトールは市販品、例えば
ピロマトール(大塚化学(株)、商品名)及びベルト
ール(フアイザー(株)、商品名)またエチルマルト
ールは市販品、例えばピロマトールE(大塚化学
(株)、商品名)及びベルトールプラス(フアイザー
(株)、市販品)を使用することができる。 本発明にて用いるマルトール及びエチルマルト
ールはGRASリスト(No.2656,No.3487)及び
FDAリスト(〓121・1164,〓121・1164)に
各々記載の既に安全性の確認された香料物質であ
り、香味剤または香味改良増強剤(Flavor
enhancer)として、例えばチヨコレート製品、
パン類、砂糖菓子、アルコール飲料、肉製品、酪
農製品、アイスクリーム、缶詰食品、タバコ、歯
磨、口紅、保健製品、動物飼料等に広く利用され
ている。〔香料化学総覧()、奥田治著、940頁、
広川書店発行〕。 この様な口腔内で快い芳香を漂わせる香料物質
がう蝕菌生育阻害剤として優れた効果を示すこと
は驚くべき事である。 本発明のマルトールとエチルマルトールとは併
用してもよく、また一方のみを単独で用いてもよ
い。 本発明のう蝕菌生育阻害剤の投与形態としては
口腔中で比較的滞留時間の長い錠果、チユーイン
ガム、キヤンデー、トローチ等に配合させること
によりその効果が期待できる外、本発明のう蝕菌
生育阻害剤は界面活性剤による抗菌活性も殆ど無
いので歯磨、マウスウオシユ等の口腔清浄剤にも
配合しても使用できる。その配合量は対象製品の
形態、種類等によつて必ずしも一様ではないが口
腔用組成物0.005%/10重量%、好ましくは0.01
〜5重量%配合するのが一般的である。 本発明のう蝕菌生育阻害剤を配合した処方例を
下記に示す。 処方例 1 常法に従い、以下に示す組成物のチユーインガ
ムを製造した。 成 分 重量% ガムベース 20 粉 糖 35 マルトース 10 フルクトース 10 水アメ 15 香 料 1 マルトール 0.4 水 残部 100% 処方例 2 常法に従い、以下に示す組成物のマウスウオツ
シユを製造した。 成 分 重量% エタノール 20 サツカリン 0.5 グリセリン 50 シヨ糖ラウリレート 2 ツロルヘキシジン 0.5 香 料 1 エチルマルトール 0.5 水 残部 100% 処方例 3 常法に従い、以下に示す組成物のトローチを製
造した。 成 分 重量% アラビアガム 8 マルトース 30 フルクトース 20 グルコース 20 香 料 0.2 マルトール 0.2 水 残部 100% (実施例) 次に本発明のマルトール及びエチルマルトール
の抗菌活性効果を実施例により本発明を更に詳細
に説明する。 実施例 1) ペプトン1%、酵母エキス0.5%、シヨ糖2%、
PH7.0の寒天培地を調製し、滅菌冷却後、これに
24時間培養したストレプトコツカス・ミユータン
ス(Streptococcus mutans)RIMD−3125001株
の培養液0.5%を添加し、直ちに直径80mmの滅菌
シヤーレに12mlづつ文注した。次に直径8mmのペ
パーデイスクに試料化合物を含させ、上記のシヤ
ーレの寒天培地中央にのせ、37℃にて72時間倒置
培養した。 抗菌活性の試験(予備テスト)の判定は次の様
にして行つた。透明な寒天培地は菌が増殖すると
白濁してくるが試料の抗菌活性が有ればペパーデ
イスク周辺は透明が保持されるので、このクリア
ゾーン(以下阻止円直径という)を測定して、そ
の阻止円直径40mm以上を増殖阻止効果が有効であ
ると評価した。
(Field of Industrial Application) The present invention is a dental carcinogen that exhibits excellent antibacterial activity against oral bacteria represented by Streptococcus mutans, which is greatly involved in the formation of dental caries. Concerning a cariogenic fungus growth inhibitor. (Prior Art) Chlorhexidine, antibiotics, and the like have been known to be used as drugs that inhibit the growth of oral bacteria, and many synthetic and natural products have been reported. (Problems to be Solved by the Invention) However, these known oral bacteria growth inhibitors may have safety issues for the human body depending on the administration method and dosage, and their stability has not been confirmed. However, it has drawbacks such as low antibacterial properties and an unpleasant odor when administered. An object of the present invention is to provide a cariogenic bacteria growth inhibitor that has been confirmed to be safe for the human body, has high antibacterial properties, and has a pleasant aroma. (Means for Solving the Problems) According to the present invention, there is provided a cariogenic fungus growth inhibitor characterized by containing maltol and/or ethyl maltol as an active ingredient. The present invention will be explained in more detail below. In general, the causes of dental caries (cavities) formation include tooth substance, substrate, and St. mutans, and when these three factors exist at the same time, caries (caries) occurs. ) is said to occur. The mechanism of caries formation is, for example, when sugar is used as a substrate among sugars, this sugar is hydrated by glucoxytransferase (enzyme) produced by St. mutans. It changes into insoluble and sticky dextran (glucan) and forms plaque on the surface of teeth. This dental plaque becomes anaerobic and fermentation progresses due to lactic acid bacteria, etc., producing lactic acid and lowering the pH. This lactic acid is said to demineralize tooth enamel and form caries (cavities). Therefore, suppressing the growth of oral bacteria such as St. mutans and inhibiting the formation of dental plaque is an effective method for preventing the formation of dental caries. The present inventors are actively searching for a substance that is compatible with the conditions of inhibiting the growth of St. mutans, which has already been confirmed to be safe for the human body and is significantly involved in caries formation. As a result of research, it was discovered that maltol and/or ethyl maltol are very effective, leading to the completion of the present invention. Maltol and ethylmaltol used in the present invention are already known substances, and the different chemical structural formulas and chemical names are shown below. 3-Hydroxy-2-methyl-4-pyrone (maltol) 3-Hydroxy-2-ethyl-4-pyrone (ethyl maltol) The maltol used in the present invention is a commercially available product, such as pyromatol (Otsuka Chemical Co., Ltd., trade name) and bertol (Phizer Co., Ltd., trade name) and ethyl maltol. Maltol is a commercially available product, such as pyromatol E (Otsuka Chemical Co., Ltd.).
Co., Ltd., product name) and Bertol Plus (Phaseiser
Co., Ltd., commercially available products) can be used. Maltol and ethyl maltol used in the present invention are listed in the GRAS list (No. 2656, No. 3487) and
It is a flavoring substance whose safety has already been confirmed and is listed on the FDA list (〓121・1164,〓121・1164), and it is a flavoring agent or flavor improvement enhancer (Flavor
enhancer), such as Chiyocolate products,
It is widely used in breads, sugar confections, alcoholic beverages, meat products, dairy products, ice cream, canned foods, tobacco, toothpaste, lipstick, health products, animal feed, etc. [Overview of Fragrance Chemistry (), Osamu Okuda, 940 pages,
Published by Hirokawa Shoten]. It is surprising that a flavoring substance that gives off a pleasant aroma in the oral cavity exhibits excellent effects as a cariogenic bacteria growth inhibitor. The maltol and ethyl maltol of the present invention may be used together, or one of them may be used alone. The cariogenic bacteria growth inhibitor of the present invention can be expected to be effective when incorporated into tablets, chewing gum, candy, troches, etc., which have a relatively long residence time in the oral cavity. Since growth inhibitors have almost no antibacterial activity due to surfactants, they can also be used in combination with oral cleansers such as toothpastes and mouthwashes. The blending amount is not necessarily uniform depending on the form and type of the target product, but it is 0.005%/10% by weight of the oral composition, preferably 0.01%.
Generally, it is blended in an amount of ~5% by weight. Examples of formulations containing the caries growth inhibitor of the present invention are shown below. Formulation Example 1 Chewing gum of the composition shown below was manufactured according to a conventional method. Ingredient weight% Gum base 20 Powder sugar 35 Maltose 10 Fructose 10 Starch syrup 15 Flavor 1 Maltol 0.4 Water Balance 100% Formulation example 2 A mouthwash of the composition shown below was produced according to a conventional method. Ingredient weight % Ethanol 20 Saccharin 0.5 Glycerin 50 Sucrose laurylate 2 Turolhexidine 0.5 Flavor 1 Ethyl maltol 0.5 Water Balance 100% Formulation Example 3 A troche of the composition shown below was produced according to a conventional method. Ingredients Weight% Gum Arabic 8 Maltose 30 Fructose 20 Glucose 20 Flavor 0.2 Maltol 0.2 Water Balance 100% (Example) Next, the antibacterial activity of maltol and ethyl maltol of the present invention will be explained in more detail by Examples. do. Example 1) Peptone 1%, yeast extract 0.5%, sucrose 2%,
Prepare an agar medium with a pH of 7.0, sterilize it, cool it, and add it to it.
0.5% of the culture solution of Streptococcus mutans RIMD-3125001 strain cultured for 24 hours was added, and 12 ml of each was immediately poured into a sterilized jar with a diameter of 80 mm. Next, a pepper disc with a diameter of 8 mm was impregnated with the sample compound, placed on the center of the above-mentioned Schare's agar medium, and cultured upside down at 37°C for 72 hours. The antibacterial activity test (preliminary test) was evaluated as follows. A transparent agar medium becomes cloudy when bacteria proliferate, but if the sample has antibacterial activity, the area around the pepper disc will remain transparent, so this clear zone (hereinafter referred to as the inhibition circle diameter) will be measured to determine the inhibition. A circle diameter of 40 mm or more was evaluated as having an effective growth inhibition effect.

【表】 表−1の結果からマルトールは優れた菌の増殖
効果を示したが、殊にエチルマルトールは極めて
著しい阻止効果を示した。 実施例 2) シヨ糖2%添加のハートインフユージヨン寒天
培地(pH7.0)を使用した以外は実施例1と同じ
ミユータンス菌を用い、同じ方法で実施した結
果、次の表−2で示される結果が得られた。
[Table] From the results shown in Table 1, maltol showed an excellent bacterial growth effect, and ethyl maltol in particular showed a very remarkable inhibiting effect. Example 2) The same method was used as in Example 1, except that a heart infusion agar medium (pH 7.0) containing 2% sucrose was used, and the results were as shown in Table 2 below. The results obtained were as follows.

【表】 表−2の結果からマルトールは優れた増殖阻止
効果を示したが、殊にエチルマルトールは極めて
著しい阻止効果を示した。 実施例 3) ストレプトコツカス・ミユータンス
(Streptococcus mutans)RIMD−3125002(E49)
株を使用する以外は実施例−1と同じ培地を用
い、同じ方法で実施した結果、次の表−3で示さ
れる結果が得られた。
[Table] From the results shown in Table 2, maltol showed an excellent growth-inhibiting effect, and ethyl maltol in particular showed a very remarkable inhibiting effect. Example 3) Streptococcus mutans RIMD-3125002 (E49)
As a result of using the same medium and the same method as in Example 1 except for using the different strains, the results shown in Table 3 below were obtained.

【表】 表−3の結果からマルトール及びエチルマルト
ールとも極めて著しい菌増殖の阻止効果を示し
た。 実施例 4) シヨ糖2%添加のハートインフユージヨンブイ
ヨンの液体培地(pH7.0)にマルトール0.02%
(1/5000濃度)添加し、これに前培養しておい
てストレプトコツカス・ミユータンス
(Streptococcus mutans)3125001株の培養液を
0.5%添加し、窒素デシケター中で37℃にて24時
間培養し、菌の生育状態をチエツクした結果、培
地のpHの低下もなく、またグルカンの形成も見
られなかつた事により、完全に菌の生育を阻止す
ることができた。また本試料の実用化を目的にソ
ジウムラウリルサルフエート0.5%の共存下にお
ける抗菌活性を測定した所、無添加と比較し何ら
活性の低下は認められなかつた。 実施例 5) 試験試料をエチルマルトール0.02%(1/5000
濃度)を使用する以外実施例−4と同じ培地
(pH7.0)、菌及び方法で実施した結果、培地の
pHの低下もなく、またグルカンの形成も見られ
なかった事により、完全に菌の生育を阻止するこ
とができた。
[Table] From the results shown in Table 3, both maltol and ethylmaltol showed extremely remarkable effects in inhibiting bacterial growth. Example 4) 0.02% maltol in a heart infusion broth liquid medium (pH 7.0) supplemented with 2% sucrose
(1/5000 concentration), precultured, and cultured with Streptococcus mutans strain 3125001.
After adding 0.5% and culturing at 37℃ for 24 hours in a nitrogen desiccator, we checked the growth status of the bacteria. As a result, there was no decrease in the pH of the culture medium and no glucan formation was observed, so the bacteria were completely destroyed. was able to prevent the growth of. In addition, for the purpose of practical use of this sample, the antibacterial activity was measured in the presence of 0.5% sodium lauryl sulfate, and no decrease in activity was observed compared to when no additive was added. Example 5) The test sample was mixed with ethyl maltol 0.02% (1/5000
As a result of carrying out the experiment using the same medium (pH 7.0), bacteria, and method as in Example 4, except that the concentration of
Since there was no decrease in pH and no glucan formation was observed, bacterial growth was completely inhibited.

Claims (1)

【特許請求の範囲】[Claims] 1 マルトール及び/またはエチルマルトールを
有効成分として含有することを特徴とするう蝕菌
生育阻害剤。
1. A caries growth inhibitor characterized by containing maltol and/or ethyl maltol as an active ingredient.
JP22897384A 1984-11-01 1984-11-01 Agent for inhibiting growth of dental caries bacteria Granted JPS61109716A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22897384A JPS61109716A (en) 1984-11-01 1984-11-01 Agent for inhibiting growth of dental caries bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22897384A JPS61109716A (en) 1984-11-01 1984-11-01 Agent for inhibiting growth of dental caries bacteria

Publications (2)

Publication Number Publication Date
JPS61109716A JPS61109716A (en) 1986-05-28
JPH0434968B2 true JPH0434968B2 (en) 1992-06-09

Family

ID=16884770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22897384A Granted JPS61109716A (en) 1984-11-01 1984-11-01 Agent for inhibiting growth of dental caries bacteria

Country Status (1)

Country Link
JP (1) JPS61109716A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2342976A1 (en) * 1998-09-23 2000-03-30 Unilever Plc Oral care compositions
ES2911516T3 (en) 2016-01-19 2022-05-19 Achromaz Pte Ltd A cosmetic composition and the use thereof for regulating skin quality

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5037260A (en) * 1973-06-23 1975-04-07
JPS5141446A (en) * 1974-08-09 1976-04-07 Procter & Gamble Shiko mushiba oyobi shisekiochensaserutameno osenkeikonogenshoshitakokoyososeibutsu
JPS51139639A (en) * 1975-04-01 1976-12-02 Procter & Gamble Tartar preventive composition
JPS568679A (en) * 1979-04-11 1981-01-29 Fichera A T Composition for controlling tobacco smoking and production thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5037260A (en) * 1973-06-23 1975-04-07
JPS5141446A (en) * 1974-08-09 1976-04-07 Procter & Gamble Shiko mushiba oyobi shisekiochensaserutameno osenkeikonogenshoshitakokoyososeibutsu
JPS51139639A (en) * 1975-04-01 1976-12-02 Procter & Gamble Tartar preventive composition
JPS568679A (en) * 1979-04-11 1981-01-29 Fichera A T Composition for controlling tobacco smoking and production thereof

Also Published As

Publication number Publication date
JPS61109716A (en) 1986-05-28

Similar Documents

Publication Publication Date Title
JP5283173B2 (en) Non-cariogenic materials and anti-cariogenic agents containing rare sugars
JPH0662408B2 (en) Anti-caries and anti-periodontal composition
JP3614479B2 (en) Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them
JP3241955B2 (en) Oral composition
JPH0140005B2 (en)
JPS61171423A (en) Drug for alleviating dental caries and periodontosis
JPH0234322B2 (en)
JPH1143442A (en) Legionella bacteria resistant composition
JPH03240721A (en) Composition for oral cavity
KR100450391B1 (en) Toothpaste Composition
JP3481269B2 (en) Antibacterial composition and antibacterial method
KR102438800B1 (en) Composition comtaining lactic acid fermented noni extract as active ingredient for prevention or treatment of oral disease
JPH0434968B2 (en)
KR20030089047A (en) Composition for enhancing oral health
JPH0639375B2 (en) Anti-caries agent
KR102269164B1 (en) Composition for improvement of dental caries and periodontal disease using an extract of seeds of Phaseolus radiatus, etc.
JPS5835484B2 (en) Oral composition
TW201117804A (en) Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria
KR102452255B1 (en) Composition comprising deacetyl asperulosidic acid and/or asperulosidic acid as active ingredient for prevention or treatment of oral disease
JP2001321123A (en) Anticariogenic food material and its composition
JP4796700B2 (en) Antibacterial oral or external medicine composition
JPS6258324B2 (en)
JP7362417B2 (en) Growth inhibitors, oral compositions, and promoters of oral pathogenic bacteria
KR102055667B1 (en) Toothpsate composites type gel tablet and that of manufacturing method
JPH0720854B2 (en) Oral composition